These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 2509120

  • 1. Erythrocyte sedimentation rate and heterotopic bone formation after cemented total hip arthroplasty.
    Kjaersgaard-Andersen P, Schmidt SA, Pedersen NW, Kristensen SS, Pedersen P.
    Clin Orthop Relat Res; 1989 Nov; (248):189-94. PubMed ID: 2509120
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty.
    Shih LY, Wu JJ, Yang DJ.
    Clin Orthop Relat Res; 1987 Dec; (225):238-46. PubMed ID: 3677512
    [Abstract] [Full Text] [Related]

  • 5. The use of aspirin to prevent heterotopic ossification after total hip arthroplasty. A preliminary report.
    Freiberg AA, Cantor R, Freiberg RA.
    Clin Orthop Relat Res; 1991 Jun; (267):93-6. PubMed ID: 1904336
    [Abstract] [Full Text] [Related]

  • 6. Short term prophylaxis against heterotopic bone after cementless hip replacement.
    Wurnig C, Auersperg V, Boehler N, Steindl M, Kiss H, Zweymuller K, Kotz R.
    Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
    Schara K, Herman S.
    Acta Chir Orthop Traumatol Cech; 2001 Jan; 68(2):105-8. PubMed ID: 11706718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty.
    Fingeroth RJ, Ahmed AQ.
    Clin Orthop Relat Res; 1995 Aug; (317):131-40. PubMed ID: 7671467
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
    Gebuhr P, Wilbek H, Soelberg M.
    Clin Orthop Relat Res; 1995 May; (314):166-9. PubMed ID: 7634631
    [Abstract] [Full Text] [Related]

  • 16. [Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis].
    Hochheim B, Wünsche F.
    Beitr Orthop Traumatol; 1990 Jun; 37(6):330-4. PubMed ID: 2117436
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial.
    Schmidt SA, Kjaersgaard-Andersen P, Pedersen NW, Kristensen SS, Pedersen P, Nielsen JB.
    J Bone Joint Surg Am; 1988 Jul; 70(6):834-8. PubMed ID: 3134359
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement].
    Heyd R, Strassmann G, Kirchner J, Schopohl B, Böttcher HD.
    Strahlenther Onkol; 1996 Oct; 172(10):543-52. PubMed ID: 8966671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.